🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrey Loboda

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0003-4239-184X

Also affiliated with Applied Science Laboratories (United States)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection”.

Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection

Nature Medicine(2021)10.1038/s41591-021-01371-0
N/A
4.7DataRank · unranked
194 citations

Shu‐Hong Lin, Alexander G. Bick, Aoxing Liu, Kaavya Paruchuri, Chen Wang +95 more

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007929
N/A
0.783DataRank · unranked
19 citations

Matthew H. Taylor, Carol Aghajanian, Allen Lee Cohn, Marcia S. Brose, Christopher Di Simone +12 more

Predictive Genes in Adjacent Normal Tissue Are Preferentially Altered by sCNV during Tumorigenesis in Liver Cancer and May Rate Limiting

PLoS ONE(2011)10.1371/journal.pone.0020090
N/A
0.666DataRank · unranked
84 citations

Chunsheng Zhang, Tao Xie, Kai Wang, Bin Zhang, Ke Hao +33 more

Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3089
N/A
0.587DataRank · unranked
49 citations

Ronald de Wit, Yves Fradet, Miguel A. Climent, Daniel P. Petrylak, Jae‐Lyun Lee +26 more

Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer

Gut(2024)10.1136/gutjnl-2024-332535
N/A
0.561DataRank · unranked
41 citations

Michelle Maurin, Jetsen A. Rodriguez-Silva, Gunjan Upadhyay, Ashley Alden, Siddabasave Gowda B. Gowda +24 more

Large-scale genome-wide analyses with proteomics integration reveal novel loci and biological insights into frailty

Nature Aging(2025)10.1038/s43587-025-00925-y
N/A
0.269DataRank · unranked
5 citations

Chenxi Qin, Moritz Krüger, Anna Kuukka, Aarno Palotie, Mark Daly +322 more

Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer

BMC Cancer(2025)10.1186/s12885-025-13829-2
N/A
0.241DataRank · unranked
4 citations

Michael Nebozhyn, Michael J. Schell, Nishant Gandhi, Lance Pflieger, Andrey Loboda +14 more

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

BMC Cancer(2022)10.1186/s12885-022-09344-3
N/A
0DataRank · unranked
22 citations

Thomas B. Davis, Lance Pflieger, Michael Nebozhyn, Andrey Loboda, Heiman Wang +5 more